Cellular Signaling and Metabolic Regulation in Chronic Liver Disease

Description

This session explores the intricate signaling pathways and metabolic networks that govern liver injury, repair, and chronic disease progression. Presentations will cover hepatocyte-stellate cell interactions, nuclear receptor signaling, autophagy zonation, and the molecular regulation of regeneration and fibrosis. Through multiomics and tissue-specific analyses, these studies illuminate how dysregulation of cellular communication and metabolism contributes to conditions such as steatohepatitis, fibrosis, sarcopenia, and Type II diabetes.

Journey Maps

Presentations

8:00 AM - 8:15 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

Beta-arrestin-2-mediated hepatocyte-HSC interaction promotes HSC activation and fibrogenesis

Romina Fiorotto, PhD , Abstract Presenter
Basic Science
8:15 AM - 8:30 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

Targeting LRH-1 in Mice Promotes Liver Homeostasis and Inflammatory Attenuating Transcriptional Profiles to Ameloriate TypeII Diabetes

Wen-Xing Ding, MD, PhD, FAASLD , Abstract Presenter
Basic Science
8:30 AM - 8:45 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

PPAR gamma regulates PNPLA3 in a tissue specific manner in obese people and mice with metabolic dysfunction-associated steatohepatitis

Romina Fiorotto, PhD , Abstract Presenter
Basic Science
8:45 AM - 9:00 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

Multiomics analysis Reveals MyD88-dependent Inhibition of mitochondrial oxidative function during hyperammonemic stress causes sarcopenia of cirrhosis

Wen-Xing Ding, MD, PhD, FAASLD , Abstract Presenter
Basic Science
9:00 AM - 9:15 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

Spatial Organellomics: A New Window into Hepatocyte Subtypes, Zonal Diversity, and Disease Progression 

Romina Fiorotto, PhD , Abstract Presenter
Basic Science
9:15 AM - 9:30 AM
Aug 06 2026
Convention Center - Room 146A, Level 1

Transcriptional Regulation of the Hepatic Acetylome by Nrf2 in Autophagy-Impaired Liver

Wen-Xing Ding, MD, PhD, FAASLD , Abstract Presenter
Basic Science

Objectives

  • Identify key signaling pathwaysincluding Wnt/-catenin, -arrestin, and nuclear receptorsthat regulate liver regeneration, fibrosis, and metabolic balance.
  • Describe how cell-specific transcriptional and metabolic regulation contributes to chronic liver disease states such as steatohepatitis, cirrhosis, and diabetes.
  • Evaluate emerging molecular insights from multiomics and zonation analyses to understand the cellular complexity of liver pathophysiology.